Benign Diseases of The Lung: Chronic Tromboembolic Pulmoner Hypertension

Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53: 1801915 [https://doi.org/10.1183/13993003.01915-2018]. J

Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53: 1801913.H.

Gall, M. M. Hoeper, M. J. Richter, W. Cacheris, B. Hinzmann, and E. Mayer, ‘An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the usa, Europe and Japan’, Eur. Respir. Rev., vol. 26, no. 143, 2017, doi: 10.1183/16000617.0121-2016..

A. Korkmaz, T. Ozlu, S. Ozsu, Z. Kazaz, and Y. Bulbul, ‘Long-term outcomes in acute pulmonary thromboembolism: The incidence of chronic thromboembolic pulmonary hypertension and associated risk factors’, Clin. Appl. Thromb., vol. 18, no. 3, pp. 281–288, 2012, doi: 10.1177/1076029611431956.

J. Pepke-Zaba et al., ‘Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry’, Circulation, vol. 124, no. 18, pp. 1973–1981, 2011, doi: 10.1161/CIRCULATIONAHA.110.015008.

E. Mayer et al., ‘Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry’, J. Thorac. Cardiovasc. Surg., vol. 141, no. 3, pp. 702–710, 2011, doi: 10.1016/j.jtcvs.2010.11.024.

S. Yang et al., ‘Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism’, J. Thorac. Dis., vol. 7, no. 11, pp. 1927–1938, 2015, doi: 10.3978/j.issn.2072-1439.2015.11.43.

D. Bonderman et al., ‘High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension’, Thromb. Haemost., vol. 90, no. 3, pp. 372–376, 2003, doi: 10.1160/th03-02-0067.

T. A. Morris et al., ‘High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension’, Blood, vol. 114, no. 9, pp. 1929–1936, 2009, doi: 10.1182/blood-2009-03-208264.

M. Wolf et al., ‘Thrombotic risk factors in pulmonary hypertension’, Eur. Respir. J., vol. 15, no. 2, pp. 395–399, 2000, doi: 10.1034/j.1399-3003.2000.15b28.x.

X. Jaïs et al., ‘Splenectomy and chronic thromboembolic pulmonary hypertension’, Thorax, vol. 60, no. 12, pp. 1031–1034, 2005, doi: 10.1136/thx.2004.038083.

D. Bonderman et al., ‘Risk factors for chronic thromboembolic pulmonary hypertension’, Eur. Respir. J., vol. 33, no. 2, pp. 325–331, 2009, doi: 10.1183/09031936.00087608.

S. Kominami et al., ‘HLA-DPB1 and NFKBIL1 may confer the susceptibility to chronic thromboembolic pulmonary hypertension in the absence of deep vein thrombosis’, J. Hum. Genet., vol. 54, no. 2, pp. 108–114, 2009, doi: 10.1038/jhg.2008.15.

D. Bonderman et al., ‘Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension’, Thromb. Haemost., 2005, doi: 10.1160/TH04-10-0657.

F. Raza et al., ‘Initial clinical and hemodynamic results of a regional pulmonary thromboendarterectomy program’, J. Cardiovasc. Surg. (Torino)., vol. 59, no. 3, pp. 428–437, 2018, doi: 10.23736/S0021-9509.17.10188-6.

D. Bonderman et al., ‘Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension’, Arterioscler. Thromb. Vasc. Biol., vol. 28, no. 4, pp. 678–684, 2008, doi: 10.1161/ATVBAHA.107.156000.

S. Alias et al., ‘Defective angiogenesis delays thrombus resolution: A potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension’, Arterioscler. Thromb. Vasc. Biol., vol. 34, no. 4, pp. 810–819, 2014, doi: 10.1161/ATVBAHA.113.302991.

J. Kellermair et al., ‘Platelet endothelial cell adhesion molecule 1 deficiency misguides venous thrombus resolution’, Blood, vol. 122, no. 19, pp. 3376–3384, 2013, doi: 10.1182/blood-2013-04-499558.

P. Dorfmüller et al., ‘Microvascular disease in chronic thromboembolic pulmonary hypertension: A role for pulmonary veins and systemic vasculature’, Eur. Respir. J., vol. 44, no. 5, pp. 1275–1288, 2014, doi: 10.1183/09031936.00169113.

K. M. Moser and C. M. Bloor, ‘Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension’, Chest, vol. 103, no. 3, pp. 685–692, 1993, doi: 10.1378/chest.103.3.685.

E. S. Yi et al., ‘Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension: A morphometric and immunohistochemical study’, Am. J. Respir. Crit. Care Med., vol. 162, no. 4 I, pp. 1577–1586, 2000, doi: 10.1164/ajrccm.162.4.9912131.

E. Fadel et al., ‘Endothelial nitric oxide synthase function in pig lung after chronic pulmonary artery obstruction’, Am. J. Respir. Crit. Care Med., vol. 162, no. 4 I, pp. 1429–1434, 2000, doi: 10.1164/ajrccm.162.4.2001010.

H. J. Reesink et al., ‘Hemodynamic and clinical correlates of endothelin-1 in chronic thromboembolic pulmonary hypertension’, Circ. J., vol. 70, no. 8, pp. 1058–1063, 2006, doi: 10.1253/circj.70.1058.

D. Taboada et al., ‘Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease’, Eur. Respir. J., vol. 44, no. 6, pp. 1635–1645, 2014, doi: 10.1183/09031936.00050114.

Olgun Yıldızeli Ş, Kepez A, Taş Serpil et al. Pulmonary endarterectomy for patients

with chronic thromboembolic disease Anatol J Cardiol 2018; 19: 273-8 274 DOI:10.14744/AnatolJCardiol.2018.37929.

N. Galiè et al., ‘2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension’, Eur. Respir. J., vol. 46, no. 4, pp. 903–975, 2015, doi: 10.1183/13993003.01032-2015.

M. Madani, E. Mayer, E. Fadel, and D. P. Jenkins, ‘Pulmonary endarterectomy: Patient selection, technical challenges, and outcomes’, Ann. Am. Thorac. Soc., vol. 13, no. July, pp. S240–S247, 2016, doi: 10.1513/AnnalsATS.201601-014AS.

W. R. Auger, P. F. Fedullo, K. M. Moser, M. Buchbinder, and K. L. Peterson, ‘Chronic major-vessel thromboembolic pulmonary artery obstruction: Appearance at angiography’, Radiology, vol. 182, no. 2, pp. 393–398, 1992, doi: 10.1148/radiology.182.2.1732955.

U. Coskun et al., ‘Pulmonary artery sarcoma masquerading as chronic pulmonary thromboembolism’, Texas Hear. Inst. J., vol. 41, no. 5, pp. 518–522, 2014, doi: 10.14503/THIJ-13-3598.

M. Çetin, K. Karaman, M. Özgökçe, H. Geylan, and B. Yildizeli, ‘Hydatid cyst involvement of both pulmonary arteries in a 14-year-old girl’, Paediatr. Int. Child Health, vol. 38, no. 4, pp. 294–297, 2018, doi: 10.1080/20469047.2017.1389808.

M. Küçük, C. R. Öncel, M. Uçar, A. B. Yildirim, and B. Yildizeli, ‘Pulmonary endarterectomy for large vessel pulmonary arteritis mimicking chronic thromboembolic disease’, Arch. Rheumatol., vol. 31, no. 1, pp. 98–101, 2016, doi: 10.5606/ArchRheumatol.2016.5674.

Ş. O. Ylldlzeli et al., ‘Outcomes of Patients with Behçet’s Syndrome after Pulmonary Endarterectomy’, Thorac. Cardiovasc. Surg., vol. 66, no. 2, pp. 187–192, 2018, doi: 10.1055/s-0037-1604411.

B. Ylldlzeli et al., ‘Pulmonary endarterectomy for chronic thrombo-embolic pulmonary hypertension: An institutional experience’, Eur. J. Cardio-thoracic Surg., vol. 44, no. 3, pp. 6–8, 2013, doi: 10.1093/ejcts/ezt293.

B. Yildizeli et al., ‘Management of massive pulmonary hemorrhage following pulmonary endarterectomy’, Thorac. Cardiovasc. Surg., vol. 62, no. 1, pp. 89–91, 2014, doi: 10.1055/s-0032-1324711.

M. M. Madani et al., ‘Pulmonary endarterectomy: Recent changes in a single institution’s experience of more than 2,700 patients’, Ann. Thorac. Surg., vol. 94, no. 1, pp. 97–103, 2012, doi: 10.1016/j.athoracsur.2012.04.004.

Y. Sakurai et al., ‘Predictors of Outcomes After Surgery for Chronic Thromboembolic Pulmonary Hypertension’, Ann. Thorac. Surg., vol. 108, no. 4, pp. 1154–1161, 2019, doi: 10.1016/j.athoracsur.2019.03.100.

W. C. Hsieh, P. Jansa, W. C. Huang, M. Nižnanský, M. Omara, and J. Lindner, ‘Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis’, J. Thorac. Cardiovasc. Surg., vol. 156, no. 3, pp. 1275–1287, 2018, doi: 10.1016/j.jtcvs.2018.04.110.